nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1A1—chronic obstructive pulmonary disease	0.159	0.397	CbGaD
Propofol—CYP1A2—chronic obstructive pulmonary disease	0.153	0.382	CbGaD
Propofol—ALB—chronic obstructive pulmonary disease	0.0886	0.221	CbGaD
Propofol—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0462	0.117	CbGbCtD
Propofol—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0462	0.117	CbGbCtD
Propofol—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.035	0.0889	CbGbCtD
Propofol—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0259	0.0658	CbGbCtD
Propofol—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.0522	CbGbCtD
Propofol—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0191	0.0485	CbGbCtD
Propofol—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0191	0.0485	CbGbCtD
Propofol—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0173	0.0438	CbGbCtD
Propofol—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0159	0.0403	CbGbCtD
Propofol—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0159	0.0403	CbGbCtD
Propofol—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.015	0.0381	CbGbCtD
Propofol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0145	0.0369	CbGbCtD
Propofol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0145	0.0369	CbGbCtD
Propofol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0129	0.0329	CbGbCtD
Propofol—ALB—Prednisone—chronic obstructive pulmonary disease	0.0124	0.0314	CbGbCtD
Propofol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0122	0.031	CbGbCtD
Propofol—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.012	0.0306	CbGbCtD
Propofol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00823	0.0209	CbGbCtD
Propofol—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00803	0.0204	CbGbCtD
Propofol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00786	0.0199	CbGbCtD
Propofol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.007	0.0178	CbGbCtD
Propofol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00411	0.0104	CbGbCtD
Propofol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00388	0.00985	CbGbCtD
Propofol—Fospropofol—ALB—chronic obstructive pulmonary disease	0.00122	1	CrCbGaD
Propofol—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00185	CcSEcCtD
Propofol—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00184	CcSEcCtD
Propofol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00183	CcSEcCtD
Propofol—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00183	CcSEcCtD
Propofol—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00182	CcSEcCtD
Propofol—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00182	CcSEcCtD
Propofol—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00181	CcSEcCtD
Propofol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000209	0.0018	CcSEcCtD
Propofol—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00178	CcSEcCtD
Propofol—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00177	CcSEcCtD
Propofol—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00177	CcSEcCtD
Propofol—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00176	CcSEcCtD
Propofol—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00175	CcSEcCtD
Propofol—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000202	0.00174	CcSEcCtD
Propofol—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00174	CcSEcCtD
Propofol—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00174	CcSEcCtD
Propofol—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00173	CcSEcCtD
Propofol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00173	CcSEcCtD
Propofol—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00173	CcSEcCtD
Propofol—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00173	CcSEcCtD
Propofol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00172	CcSEcCtD
Propofol—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00172	CcSEcCtD
Propofol—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000197	0.0017	CcSEcCtD
Propofol—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0017	CcSEcCtD
Propofol—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00169	CcSEcCtD
Propofol—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00167	CcSEcCtD
Propofol—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00167	CcSEcCtD
Propofol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00165	CcSEcCtD
Propofol—Cough—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00165	CcSEcCtD
Propofol—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00164	CcSEcCtD
Propofol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00163	CcSEcCtD
Propofol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00163	CcSEcCtD
Propofol—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00163	CcSEcCtD
Propofol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00162	CcSEcCtD
Propofol—Cough—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00162	CcSEcCtD
Propofol—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00161	CcSEcCtD
Propofol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00161	CcSEcCtD
Propofol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00161	CcSEcCtD
Propofol—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00161	CcSEcCtD
Propofol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00161	CcSEcCtD
Propofol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00161	CcSEcCtD
Propofol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000186	0.0016	CcSEcCtD
Propofol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000186	0.0016	CcSEcCtD
Propofol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.0016	CcSEcCtD
Propofol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.0016	CcSEcCtD
Propofol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.0016	CcSEcCtD
Propofol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0016	CcSEcCtD
Propofol—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000185	0.0016	CcSEcCtD
Propofol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00158	CcSEcCtD
Propofol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00157	CcSEcCtD
Propofol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00157	CcSEcCtD
Propofol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00157	CcSEcCtD
Propofol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00157	CcSEcCtD
Propofol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00156	CcSEcCtD
Propofol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00154	CcSEcCtD
Propofol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00154	CcSEcCtD
Propofol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00154	CcSEcCtD
Propofol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00154	CcSEcCtD
Propofol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00154	CcSEcCtD
Propofol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00152	CcSEcCtD
Propofol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00152	CcSEcCtD
Propofol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00152	CcSEcCtD
Propofol—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00151	CcSEcCtD
Propofol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00151	CcSEcCtD
Propofol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00151	CcSEcCtD
Propofol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00151	CcSEcCtD
Propofol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00151	CcSEcCtD
Propofol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00151	CcSEcCtD
Propofol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00151	CcSEcCtD
Propofol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00149	CcSEcCtD
Propofol—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00148	CcSEcCtD
Propofol—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00146	CcSEcCtD
Propofol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00146	CcSEcCtD
Propofol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00146	CcSEcCtD
Propofol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00144	CcSEcCtD
Propofol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00144	CcSEcCtD
Propofol—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00144	CcSEcCtD
Propofol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00143	CcSEcCtD
Propofol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00143	CcSEcCtD
Propofol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00143	CcSEcCtD
Propofol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00142	CcSEcCtD
Propofol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00141	CcSEcCtD
Propofol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.0014	CcSEcCtD
Propofol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000163	0.0014	CcSEcCtD
Propofol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00139	CcSEcCtD
Propofol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00139	CcSEcCtD
Propofol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00139	CcSEcCtD
Propofol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00138	CcSEcCtD
Propofol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00137	CcSEcCtD
Propofol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00137	CcSEcCtD
Propofol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00137	CcSEcCtD
Propofol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00137	CcSEcCtD
Propofol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00137	CcSEcCtD
Propofol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00136	CcSEcCtD
Propofol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00136	CcSEcCtD
Propofol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00135	CcSEcCtD
Propofol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00134	CcSEcCtD
Propofol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00134	CcSEcCtD
Propofol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00133	CcSEcCtD
Propofol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00133	CcSEcCtD
Propofol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00133	CcSEcCtD
Propofol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00132	CcSEcCtD
Propofol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00132	CcSEcCtD
Propofol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00132	CcSEcCtD
Propofol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00131	CcSEcCtD
Propofol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000151	0.0013	CcSEcCtD
Propofol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.0013	CcSEcCtD
Propofol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00129	CcSEcCtD
Propofol—Pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00129	CcSEcCtD
Propofol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00129	CcSEcCtD
Propofol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00129	CcSEcCtD
Propofol—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00128	CcSEcCtD
Propofol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00128	CcSEcCtD
Propofol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00128	CcSEcCtD
Propofol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00128	CcSEcCtD
Propofol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00127	CcSEcCtD
Propofol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00127	CcSEcCtD
Propofol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00127	CcSEcCtD
Propofol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00127	CcSEcCtD
Propofol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00126	CcSEcCtD
Propofol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00126	CcSEcCtD
Propofol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00125	CcSEcCtD
Propofol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00123	CcSEcCtD
Propofol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00123	CcSEcCtD
Propofol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Propofol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Propofol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Propofol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Propofol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Propofol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00121	CcSEcCtD
Propofol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.0012	CcSEcCtD
Propofol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.0012	CcSEcCtD
Propofol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Propofol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Propofol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Propofol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Propofol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Propofol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00119	CcSEcCtD
Propofol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00119	CcSEcCtD
Propofol—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00118	CcSEcCtD
Propofol—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00118	CcSEcCtD
Propofol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00117	CcSEcCtD
Propofol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00117	CcSEcCtD
Propofol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00116	CcSEcCtD
Propofol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00115	CcSEcCtD
Propofol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00115	CcSEcCtD
Propofol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00114	CcSEcCtD
Propofol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00113	CcSEcCtD
Propofol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00111	CcSEcCtD
Propofol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00111	CcSEcCtD
Propofol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00109	CcSEcCtD
Propofol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00109	CcSEcCtD
Propofol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00108	CcSEcCtD
Propofol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00107	CcSEcCtD
Propofol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00106	CcSEcCtD
Propofol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00106	CcSEcCtD
Propofol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00105	CcSEcCtD
Propofol—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00105	CcSEcCtD
Propofol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00104	CcSEcCtD
Propofol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00104	CcSEcCtD
Propofol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00103	CcSEcCtD
Propofol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00103	CcSEcCtD
Propofol—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00102	CcSEcCtD
Propofol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00102	CcSEcCtD
Propofol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00102	CcSEcCtD
Propofol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000999	CcSEcCtD
Propofol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000996	CcSEcCtD
Propofol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00098	CcSEcCtD
Propofol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00098	CcSEcCtD
Propofol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000972	CcSEcCtD
Propofol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000972	CcSEcCtD
Propofol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000971	CcSEcCtD
Propofol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000971	CcSEcCtD
Propofol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000966	CcSEcCtD
Propofol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000966	CcSEcCtD
Propofol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000963	CcSEcCtD
Propofol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000963	CcSEcCtD
Propofol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00096	CcSEcCtD
Propofol—Rash—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000952	CcSEcCtD
Propofol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000951	CcSEcCtD
Propofol—Depression—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000949	CcSEcCtD
Propofol—Headache—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000946	CcSEcCtD
Propofol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000938	CcSEcCtD
Propofol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000935	CcSEcCtD
Propofol—FAAH—bronchus—chronic obstructive pulmonary disease	0.000108	0.109	CbGeAlD
Propofol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000933	CcSEcCtD
Propofol—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000933	CcSEcCtD
Propofol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000926	CcSEcCtD
Propofol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000918	CcSEcCtD
Propofol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000918	CcSEcCtD
Propofol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000917	CcSEcCtD
Propofol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000916	CcSEcCtD
Propofol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000916	CcSEcCtD
Propofol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000912	CcSEcCtD
Propofol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000899	CcSEcCtD
Propofol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000897	CcSEcCtD
Propofol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000887	CcSEcCtD
Propofol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000883	CcSEcCtD
Propofol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00087	CcSEcCtD
Propofol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000865	CcSEcCtD
Propofol—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.000859	CcSEcCtD
Propofol—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000854	CcSEcCtD
Propofol—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.00085	CcSEcCtD
Propofol—FAAH—trachea—chronic obstructive pulmonary disease	9.72e-05	0.0982	CbGeAlD
Propofol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.68e-05	0.000835	CcSEcCtD
Propofol—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.68e-05	0.000835	CcSEcCtD
Propofol—Shock—Prednisolone—chronic obstructive pulmonary disease	9.52e-05	0.000822	CcSEcCtD
Propofol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.45e-05	0.000815	CcSEcCtD
Propofol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.36e-05	0.000807	CcSEcCtD
Propofol—Flushing—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000793	CcSEcCtD
Propofol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.000763	CcSEcCtD
Propofol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.76e-05	0.000755	CcSEcCtD
Propofol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.00075	CcSEcCtD
Propofol—Erythema—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.000744	CcSEcCtD
Propofol—Pain—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000714	CcSEcCtD
Propofol—CYP2C18—bronchus—chronic obstructive pulmonary disease	8.27e-05	0.0836	CbGeAlD
Propofol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.98e-05	0.000688	CcSEcCtD
Propofol—Agitation—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000683	CcSEcCtD
Propofol—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000679	CcSEcCtD
Propofol—Syncope—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000667	CcSEcCtD
Propofol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.69e-05	0.000663	CcSEcCtD
Propofol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000654	CcSEcCtD
Propofol—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000644	CcSEcCtD
Propofol—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.44e-05	0.000642	CcSEcCtD
Propofol—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000633	CcSEcCtD
Propofol—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000631	CcSEcCtD
Propofol—Oedema—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000607	CcSEcCtD
Propofol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000607	CcSEcCtD
Propofol—FAAH—lung—chronic obstructive pulmonary disease	6.99e-05	0.0706	CbGeAlD
Propofol—Shock—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000597	CcSEcCtD
Propofol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000592	CcSEcCtD
Propofol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000587	CcSEcCtD
Propofol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000553	CcSEcCtD
Propofol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000552	CcSEcCtD
Propofol—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000549	CcSEcCtD
Propofol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000545	CcSEcCtD
Propofol—Rash—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.000527	CcSEcCtD
Propofol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.000526	CcSEcCtD
Propofol—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000523	CcSEcCtD
Propofol—Headache—Prednisolone—chronic obstructive pulmonary disease	6.06e-05	0.000523	CcSEcCtD
Propofol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.0005	CcSEcCtD
Propofol—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.75e-05	0.000496	CcSEcCtD
Propofol—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000482	CcSEcCtD
Propofol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.00048	CcSEcCtD
Propofol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.00048	CcSEcCtD
Propofol—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000435	CcSEcCtD
Propofol—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000429	CcSEcCtD
Propofol—GABRB3—respiratory system—chronic obstructive pulmonary disease	4.93e-05	0.0498	CbGeAlD
Propofol—CYP1B1—respiratory system—chronic obstructive pulmonary disease	4.87e-05	0.0492	CbGeAlD
Propofol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000415	CcSEcCtD
Propofol—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000401	CcSEcCtD
Propofol—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000386	CcSEcCtD
Propofol—Rash—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000383	CcSEcCtD
Propofol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000382	CcSEcCtD
Propofol—Headache—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.00038	CcSEcCtD
Propofol—GABRB3—connective tissue—chronic obstructive pulmonary disease	4.34e-05	0.0439	CbGeAlD
Propofol—CYP1B1—connective tissue—chronic obstructive pulmonary disease	4.29e-05	0.0433	CbGeAlD
Propofol—Nausea—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.00036	CcSEcCtD
Propofol—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	3.92e-05	0.0396	CbGeAlD
Propofol—CYP2A6—lung—chronic obstructive pulmonary disease	3.53e-05	0.0356	CbGeAlD
Propofol—CYP1A2—respiratory system—chronic obstructive pulmonary disease	3.49e-05	0.0352	CbGeAlD
Propofol—CYP1A1—respiratory system—chronic obstructive pulmonary disease	3.44e-05	0.0348	CbGeAlD
Propofol—GABRB2—lung—chronic obstructive pulmonary disease	3.41e-05	0.0345	CbGeAlD
Propofol—CYP2B6—respiratory system—chronic obstructive pulmonary disease	3.35e-05	0.0338	CbGeAlD
Propofol—CYP2E1—respiratory system—chronic obstructive pulmonary disease	3.14e-05	0.0317	CbGeAlD
Propofol—CYP1A1—bronchus—chronic obstructive pulmonary disease	2.83e-05	0.0286	CbGeAlD
Propofol—CYP2B6—bronchus—chronic obstructive pulmonary disease	2.75e-05	0.0278	CbGeAlD
Propofol—GABRB3—lung—chronic obstructive pulmonary disease	2.62e-05	0.0265	CbGeAlD
Propofol—CYP1B1—lung—chronic obstructive pulmonary disease	2.59e-05	0.0261	CbGeAlD
Propofol—CYP1A1—trachea—chronic obstructive pulmonary disease	2.54e-05	0.0257	CbGeAlD
Propofol—CYP1A2—lung—chronic obstructive pulmonary disease	1.85e-05	0.0187	CbGeAlD
Propofol—CYP1A1—lung—chronic obstructive pulmonary disease	1.83e-05	0.0185	CbGeAlD
Propofol—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.82e-05	0.000209	CbGpPWpGaD
Propofol—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	1.82e-05	0.000209	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000205	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.78e-05	0.000205	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.78e-05	0.000205	CbGpPWpGaD
Propofol—CYP2B6—lung—chronic obstructive pulmonary disease	1.78e-05	0.0179	CbGeAlD
Propofol—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.000202	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000202	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000199	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—ALB—chronic obstructive pulmonary disease	1.73e-05	0.000198	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	1.73e-05	0.000198	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000198	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000198	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000196	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.7e-05	0.000195	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.7e-05	0.000195	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.67e-05	0.000192	CbGpPWpGaD
Propofol—CYP2E1—lung—chronic obstructive pulmonary disease	1.67e-05	0.0168	CbGeAlD
Propofol—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.66e-05	0.00019	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.65e-05	0.00019	CbGpPWpGaD
Propofol—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	1.65e-05	0.000189	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000183	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000182	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.000179	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.56e-05	0.000179	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000179	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.000178	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.54e-05	0.000177	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.54e-05	0.000177	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.52e-05	0.000174	CbGpPWpGaD
Propofol—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.48e-05	0.00017	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.000169	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000168	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.45e-05	0.000167	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000166	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000166	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.43e-05	0.000165	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.43e-05	0.000164	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000164	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.42e-05	0.000163	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000162	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.41e-05	0.000162	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000161	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.39e-05	0.00016	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000158	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000158	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.36e-05	0.000157	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000156	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000156	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000156	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.35e-05	0.000155	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000155	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000155	CbGpPWpGaD
Propofol—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.34e-05	0.000154	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000154	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.34e-05	0.000154	CbGpPWpGaD
Propofol—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.33e-05	0.000153	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.33e-05	0.000153	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000153	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.31e-05	0.000151	CbGpPWpGaD
Propofol—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.00015	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000149	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000147	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000146	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.27e-05	0.000146	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000145	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000144	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000144	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000143	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000141	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000141	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.22e-05	0.00014	CbGpPWpGaD
Propofol—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.000139	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.2e-05	0.000138	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.2e-05	0.000138	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000137	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000137	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000136	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000135	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.17e-05	0.000135	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000134	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000132	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.00013	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.00013	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.11e-05	0.000127	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.000126	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000126	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.09e-05	0.000126	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000125	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.09e-05	0.000125	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000125	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.08e-05	0.000124	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000123	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000121	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000121	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.00012	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000119	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000119	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000116	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1e-05	0.000115	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.92e-06	0.000114	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.72e-06	0.000112	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.66e-06	0.000111	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	9.64e-06	0.000111	CbGpPWpGaD
Propofol—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	9.52e-06	0.000109	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.46e-06	0.000109	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.43e-06	0.000108	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.43e-06	0.000108	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.38e-06	0.000108	CbGpPWpGaD
Propofol—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	9.34e-06	0.000107	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.3e-06	0.000107	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.3e-06	0.000107	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	9.12e-06	0.000105	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	8.85e-06	0.000102	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.8e-06	0.000101	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.72e-06	0.0001	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.68e-06	9.97e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.67e-06	9.97e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	9.96e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	9.96e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	8.58e-06	9.87e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.48e-06	9.75e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.46e-06	9.73e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.37e-06	9.62e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.29e-06	9.53e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	9.45e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	9.45e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.19e-06	9.42e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.08e-06	9.29e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.91e-06	9.09e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.82e-06	8.98e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.73e-06	8.88e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.66e-06	8.81e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.63e-06	8.78e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.48e-06	8.6e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.27e-06	8.36e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.24e-06	8.32e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	7.23e-06	8.31e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.2e-06	8.28e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.17e-06	8.24e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.17e-06	8.24e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.12e-06	8.19e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	7.08e-06	8.14e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	7.07e-06	8.12e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.05e-06	8.1e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	7.04e-06	8.1e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.04e-06	8.09e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.03e-06	8.09e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	6.9e-06	7.93e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.89e-06	7.92e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	6.76e-06	7.77e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.76e-06	7.77e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-06	7.68e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.6e-06	7.59e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.55e-06	7.52e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.5e-06	7.47e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.46e-06	7.43e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	6.43e-06	7.39e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.4e-06	7.35e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.33e-06	7.28e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	6.32e-06	7.27e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.96e-06	6.85e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.92e-06	6.81e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.89e-06	6.78e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.88e-06	6.76e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.87e-06	6.74e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.83e-06	6.7e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.82e-06	6.68e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.79e-06	6.65e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	5.77e-06	6.63e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.76e-06	6.63e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.75e-06	6.61e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.67e-06	6.51e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	6.42e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	6.42e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.42e-06	6.23e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.39e-06	6.2e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.38e-06	6.18e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.34e-06	6.14e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.34e-06	6.14e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.34e-06	6.14e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.32e-06	6.11e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.31e-06	6.1e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.28e-06	6.07e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.26e-06	6.05e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	5.21e-06	5.99e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.11e-06	5.87e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.01e-06	5.75e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.98e-06	5.73e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-06	5.73e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.98e-06	5.72e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.97e-06	5.71e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.97e-06	5.71e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.94e-06	5.68e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.93e-06	5.66e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.9e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.89e-06	5.62e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.87e-06	5.6e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.85e-06	5.57e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.59e-06	5.28e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.56e-06	5.25e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.56e-06	5.24e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.54e-06	5.22e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.5e-06	5.17e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.43e-06	5.1e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.37e-06	5.03e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.33e-06	4.97e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	4.31e-06	4.95e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.3e-06	4.95e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-06	4.73e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.08e-06	4.69e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.07e-06	4.68e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.04e-06	4.65e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.02e-06	4.62e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-06	4.58e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.86e-06	4.44e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.85e-06	4.42e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.8e-06	4.37e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	3.76e-06	4.32e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.75e-06	4.31e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.71e-06	4.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.55e-06	4.08e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-06	4.05e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.47e-06	3.99e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.47e-06	3.99e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.45e-06	3.97e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.41e-06	3.92e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	3.4e-06	3.91e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.32e-06	3.82e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.25e-06	3.74e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.21e-06	3.69e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.2e-06	3.67e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.17e-06	3.65e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.07e-06	3.53e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.01e-06	3.46e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	2.94e-06	3.38e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.81e-06	3.23e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-06	3.22e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.67e-06	3.06e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.63e-06	3.02e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.63e-06	3.02e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.51e-06	2.89e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.45e-06	2.82e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.41e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.39e-06	2.75e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.32e-06	2.67e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.31e-06	2.66e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	2.63e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.05e-06	2.35e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.96e-06	2.25e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.58e-06	1.81e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.51e-06	1.74e-05	CbGpPWpGaD
